Dr Reddy’s to buy UK firm's nicotine gum biz for Rs5k crore
Dr Reddy's Laboratories is set to acquire Haleon Plc's NRT business, including Nicotinell, for GBP 500 million. The deal encompasses various NRT formats and potential contingent payments. This acquisition marks a significant step for Dr Reddy's in strengthening its position in the global consumer healthcare market outside the US.
Dr Reddy's Laboratories is set to acquire Haleon Plc's NRT business, including Nicotinell, for GBP 500 million. The deal encompasses various NRT formats and potential contingent payments. This acquisition marks a significant step for Dr Reddy's in strengthening its position in the global consumer healthcare market outside the US.
